Karyopharm Therapeutics
Victoria Vargo is a seasoned professional in clinical supply management with extensive experience in the pharmaceutical industry. Currently serving as Director of Clinical Supply at Karyopharm Therapeutics Inc. since April 2018, Victoria has effectively coordinated clinical distribution efforts and developed comprehensive supply plans for clinical trials. Previous roles include Trial Supply Manager at Johnson & Johnson and Clinical Supplies Project Manager at Sharp Clinical Services, where Victoria ensured compliance with regulatory standards and managed inventory during clinical trials. Victoria holds a Bachelor of Science in Communications and Management from Drexel University and an Associate of Science in Business Administration from Montgomery County Community College. Additionally, Victoria has experience in customer service and operations management within various industries.
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).